Literature DB >> 31127527

Activation of Peroxisome Proliferator-Activated Receptor-α Increases the Expression of Nuclear Receptor Related 1 Protein (Nurr1) in Dopaminergic Neurons.

Carl G Gottschalk1, Avik Roy1,2, Malabendu Jana1,2, Madhuchhanda Kundu1, Kalipada Pahan3,4.   

Abstract

Nuclear receptor related 1 protein (Nurr1) is an important transcription factor required for differentiation and maintenance of midbrain dopaminergic (DA) neurons. Since decrease in Nurr1 function either due to diminished expression or rare mutation is associated with Parkinson's disease (PD), upregulation of Nurr1 may be beneficial for PD. However, such mechanisms are poorly understood. This study underlines the importance of peroxisome proliferator-activated receptor (PPAR)α in controlling the transcription of Nurr1. Our mRNA analyses followed by different immunoassays clearly indicated that PPARα agonist gemfibrozil strongly upregulated the expression of Nurr1 in wild-type, but not PPARα-/-, DA neurons. Moreover, identification of conserved PPRE in the promoter of Nurr1 gene followed by chromatin immunoprecipitation analysis, PPRE luciferase assay, and manipulation of Nurr1 gene by viral transduction of different PPARα plasmids confirmed that PPARα was indeed involved in the expression of Nurr1. Finally, oral administration of gemfibrozil increased Nurr1 expression in vivo in nigra of wild-type, but not PPARα-/-, mice identifying PPARα as a novel regulator of Nurr1 expression and associated protection of DA neurons.

Entities:  

Keywords:  Dopaminergic neurons; Gemfibrozil; Nurr1; PPARα; Parkinson’s disease

Mesh:

Substances:

Year:  2019        PMID: 31127527      PMCID: PMC8174404          DOI: 10.1007/s12035-019-01649-y

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  57 in total

Review 1.  Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.

Authors:  Ernest Arenas
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

2.  Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition.

Authors:  M Vázquez; M Merlos; T Adzet; J C Laguna
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 3.  Prospects of statins in Parkinson disease.

Authors:  Avik Roy; Kalipada Pahan
Journal:  Neuroscientist       Date:  2011-01-20       Impact factor: 7.519

4.  Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.

Authors:  Grant T Corbett; Frank J Gonzalez; Kalipada Pahan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

5.  A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro.

Authors:  Sean L Hammond; Stephen Safe; Ronald B Tjalkens
Journal:  Neurosci Lett       Date:  2015-09-14       Impact factor: 3.046

6.  A Nurr1 point mutant, implicated in Parkinson's disease, uncouples ERK1/2-dependent regulation of tyrosine hydroxylase transcription.

Authors:  Kirsten X Jacobsen; Heather MacDonald; Sylvie Lemonde; Mireille Daigle; David A Grimes; Dennis E Bulman; Paul R Albert
Journal:  Neurobiol Dis       Date:  2007-08-21       Impact factor: 5.996

7.  A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death.

Authors:  Kaoru Saijo; Beate Winner; Christian T Carson; Jana G Collier; Leah Boyer; Michael G Rosenfeld; Fred H Gage; Christopher K Glass
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

8.  Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.

Authors:  Sang-Min Oh; Mi-Yoon Chang; Jae-Jin Song; Yong-Hee Rhee; Eun-Hye Joe; Hyun-Seob Lee; Sang-Hoon Yi; Sang-Hun Lee
Journal:  EMBO Mol Med       Date:  2016-02-01       Impact factor: 12.137

9.  Identification and characterization of PPARα ligands in the hippocampus.

Authors:  Avik Roy; Madhuchhanda Kundu; Malabendu Jana; Rama K Mishra; Yeni Yung; Chi-Hao Luan; Frank J Gonzalez; Kalipada Pahan
Journal:  Nat Chem Biol       Date:  2016-10-17       Impact factor: 15.040

10.  Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor α.

Authors:  Avik Roy; Malabendu Jana; Grant T Corbett; Shilpa Ramaswamy; Jeffrey H Kordower; Frank J Gonzalez; Kalipada Pahan
Journal:  Cell Rep       Date:  2013-08-22       Impact factor: 9.423

View more
  2 in total

1.  Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.

Authors:  Carl G Gottschalk; Malabendu Jana; Avik Roy; Dhruv R Patel; Kalipada Pahan
Journal:  J Neurosci       Date:  2021-01-29       Impact factor: 6.167

2.  Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.

Authors:  Ramesh K Paidi; Malabendu Jana; Rama K Mishra; Debashis Dutta; Kalipada Pahan
Journal:  J Immunol       Date:  2021-10-13       Impact factor: 5.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.